Home Nitriles Propanedinitrile,2-[(3-hydroxy-4-nitrophenyl)methylene]-

Propanedinitrile,2-[(3-hydroxy-4-nitrophenyl)methylene]-

CAS No.:
118409-62-4
Catalog Number:
AG007QB4
Molecular Formula:
C10H5N3O3
Molecular Weight:
215.1650
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥95%
1 week
United States
$91
- +
5mg
≥95%
1 week
United States
$161
- +
10mg
≥95%
1 week
United States
$248
- +
25mg
98%
1 week
United States
$490
- +
50mg
98%
1 week
United States
$840
- +
100mg
98%
1 week
United States
$1457
- +
Product Description
Catalog Number:
AG007QB4
Chemical Name:
Propanedinitrile,2-[(3-hydroxy-4-nitrophenyl)methylene]-
CAS Number:
118409-62-4
Molecular Formula:
C10H5N3O3
Molecular Weight:
215.1650
MDL Number:
MFCD00236448
IUPAC Name:
2-[(3-hydroxy-4-nitrophenyl)methylidene]propanedinitrile
InChI:
InChI=1S/C10H5N3O3/c11-5-8(6-12)3-7-1-2-9(13(15)16)10(14)4-7/h1-4,14H
InChI Key:
DUQADSPERJRQBW-UHFFFAOYSA-N
SMILES:
N#CC(=Cc1ccc(c(c1)O)[N+](=O)[O-])C#N
UNII:
7YA4AMD1JC
Properties
Complexity:
388  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
215.033g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
215.168g/mol
Monoisotopic Mass:
215.033g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
114A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2  
Literature
Title Journal
Benzylidenemalononitrile compounds as activators of cell resistance to oxidative stress and modulators of multiple signaling pathways. A structure-activity relationship study. Biochemical pharmacology 20110901
Stage-specific expression of TNFα regulates bad/bid-mediated apoptosis and RIP1/ROS-mediated secondary necrosis in Birnavirus-infected fish cells. PloS one 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Tyrosine kinase inhibitor AG126 reduces 7-ketocholesterol-induced cell death by suppressing mitochondria-mediated apoptotic process. Neurochemical research 20100401
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American journal of physiology. Heart and circulatory physiology 20090201
Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma. Neuropharmacology 20070601
Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid. The Journal of pharmacology and experimental therapeutics 20070201
A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Molecular pharmacology 20060401
Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery 20051101
Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and release. Journal of leukocyte biology 20040901
The tyrosine kinase inhibitor AG126 restores receptor signaling and blocks release functions in activated microglia (brain macrophages) by preventing a chronic rise in the intracellular calcium level. Journal of neurochemistry 20040801
Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040601
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis. Experimental and molecular pathology 20040601
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. American journal of physiology. Cell physiology 20040501
Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cellular microbiology 20031201
The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat. Kidney international 20031101
Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis. Investigative ophthalmology & visual science 20030401
Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. BMC ophthalmology 20030101
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat. Intensive care medicine 20020601
Tyrphostins inhibit lipopolysaccharide induced preterm labor in mice. Journal of perinatal medicine 20020101
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome. Leukemia 20011101
The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. European journal of immunology 20010701
ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. The Journal of biological chemistry 20010209
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. Journal of medicinal chemistry 19891001
Properties